Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingming Wei

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|August 22, 2020
Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancerMingming Wei, Maodun Xie, Zhen Zhang, et al.
Journal of Medicinal Chemistry|June 15, 2021
Discovery and Optimization of a Novel 2<i>H</i>-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor InhibitorYujiao Wei, Yanting Tang, Yunyun Zhou, et al.
Bioorganic & Medicinal Chemistry|February 22, 2023
Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2Yetong Cui, Ruonan Wang, Yujiao Wei, et al.
Angewandte Chemie (International Ed. in English)|March 4, 2024
Discovery of Selective and Potent ATR Degrader for Exploration its Kinase-Independent Functions in Acute Myeloid Leukemia CellsYubo Wang, Ruonan Wang, Yanli Zhao, et al.
Journal of Medicinal Chemistry|August 5, 2021
5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2Mingming Wei, Yunyun Zhou, Chong Li, et al.
European Journal of Medicinal Chemistry|December 1, 2020
First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivoMingming Wei, Rui Zhao, Yuting Cao, et al.
Journal of Medicinal Chemistry|October 27, 2021
A Novel Anticancer Stem Cell Compound Derived from Pleuromutilin Induced Necroptosis of Melanoma CellsKun Zhang, Wei Song, Mingming Wei, et al.
Acta Pharmaceutica Sinica. B|September 23, 2024
Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDHZiqi Huang, Kun Zhang, Yurui Jiang, et al.
Science (New York, N.Y.)|May 10, 2014
Direct, nonoxidative conversion of methane to ethylene, aromatics, and hydrogenXiaoguang Guo, Guangzong Fang, Gang Li, et al.
European Journal of Medicinal Chemistry|July 15, 2018
A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathwayShuangwei Liu, Xian Gao, Lisong Zhang, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|August 22, 2020
Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancerMingming Wei, Maodun Xie, Zhen Zhang, et al.
Journal of Medicinal Chemistry|June 15, 2021
Discovery and Optimization of a Novel 2<i>H</i>-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor InhibitorYujiao Wei, Yanting Tang, Yunyun Zhou, et al.
Bioorganic & Medicinal Chemistry|February 22, 2023
Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2Yetong Cui, Ruonan Wang, Yujiao Wei, et al.
Angewandte Chemie (International Ed. in English)|March 4, 2024
Discovery of Selective and Potent ATR Degrader for Exploration its Kinase-Independent Functions in Acute Myeloid Leukemia CellsYubo Wang, Ruonan Wang, Yanli Zhao, et al.
Journal of Medicinal Chemistry|August 5, 2021
5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2Mingming Wei, Yunyun Zhou, Chong Li, et al.
European Journal of Medicinal Chemistry|December 1, 2020
First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivoMingming Wei, Rui Zhao, Yuting Cao, et al.
Journal of Medicinal Chemistry|October 27, 2021
A Novel Anticancer Stem Cell Compound Derived from Pleuromutilin Induced Necroptosis of Melanoma CellsKun Zhang, Wei Song, Mingming Wei, et al.
Acta Pharmaceutica Sinica. B|September 23, 2024
Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDHZiqi Huang, Kun Zhang, Yurui Jiang, et al.
Science (New York, N.Y.)|May 10, 2014
Direct, nonoxidative conversion of methane to ethylene, aromatics, and hydrogenXiaoguang Guo, Guangzong Fang, Gang Li, et al.
European Journal of Medicinal Chemistry|July 15, 2018
A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathwayShuangwei Liu, Xian Gao, Lisong Zhang, et al.
Pageof 7